J. Biochem, 1998, Vol. 123, No. 6 1127-1136
© 1998 Japanese Biochemical Society
research-article |
Clusters of Basic Amino Acids in Midkine: Roles in Neurite-Promoting Activity and Plasminogen Activator-Enhancing Activity1
*Department of Biochemistry, Nagoya University School of Medicine 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550
The Laboratory of Gene Technology and Safety, The Institute of Physical and Chemical Research (RIKEN) Koyadai, Tsukuba, Ibaraki 305-0074
Peptide Institute Inc. 4-1-2, Ina, Minoh, Osaka 562-0015
§Department of Biological Function and Analysis, Faculty of Pharmacy, Meijo University Nagoya 468-0077
¶Department of Molecular Physiology, Tokyo Metropolitan Institute of Medical Science 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-0021
2To whom correspondence should be addressed.
The removal of N-terminally located clusters of basic amino acids (N-tail) or C-terminally located clusters of basic amino acids (C-tail) from the midkine (MK) molecule severely reduced its neurite-promoting activity. However, experiments involving chemically synthesized MK derivatives revealed that the roles of the N-tail and C-tail were mostly indirect ones, i.e. they probably maintain the steric arrangements of the N-terminal and C-terminal halves. In particular, the C-domain, which is the C-terminal half devoid of the C-tail, retained considerable neurite-promoting activity when it was uniformly coated on a dish. The removal of the N-tail or C-tail also reduced the enhancing activity of plasminogen activator (PA) in aortic endothelial cells, although the effect was lower. There are two heparin-binding sites in the C-domain, Clusters I and II. A mutation in Cluster I [R78
Q] affected the PA-enhancing activity only slightly, and a mutation in Cluster II [K83K74QQ] abolished the activity, while both mutations are known to reduce the neurite-promoting activity moderately. Therefore, the two heparin-binding sites in the C-domain play different roles in these two activities. Indeed, heparin exhibited different effects on these two activities. We also observed that intact MK was required for ordered neurite-promotion along the path of MK; one possible interpretation of this is that the N-terminal half is necessary for the stability of the molecule. Furthermore, K76 and K99 were found to be required for the secretion of MK; i.e. mutants in which one of these K residues was changed to Q were produced in the host cells, but not found in the medium.
1This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Ichihara-Tanaka, A. Oohira, M. Rumsby, and T. Muramatsu Neuroglycan C Is a Novel Midkine Receptor Involved in Process Elongation of Oligodendroglial Precursor-like Cells J. Biol. Chem., October 13, 2006; 281(41): 30857 - 30864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sumi, H. Muramatsu, Y. Takei, K.-I. Hata, M. Ueda, and T. Muramatsu Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model J. Cell Sci., January 7, 2002; 115(13): 2659 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Maeda, K. Ichihara-Tanaka, T. Kimura, K. Kadomatsu, T. Muramatsu, and M. Noda A Receptor-like Protein-tyrosine Phosphatase PTPzeta /RPTPbeta Binds a Heparin-binding Growth Factor Midkine. INVOLVEMENT OF ARGININE 78 OF MIDKINE IN THE HIGH AFFINITY BINDING TO PTPzeta J. Biol. Chem., April 30, 1999; 274(18): 12474 - 12479. [Abstract] [Full Text] [PDF]
|
|